Brett D. Allison

584 total citations
15 papers, 344 citations indexed

About

Brett D. Allison is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brett D. Allison has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brett D. Allison's work include Chemical Synthesis and Analysis (5 papers), Neuropeptides and Animal Physiology (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Brett D. Allison is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Neuropeptides and Animal Physiology (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Brett D. Allison collaborates with scholars based in United States and United Kingdom. Brett D. Allison's co-authors include David A. Evans, Michael G. Yang, C. E. Masse, Neelakandha S. Mani, Cheryl A. Grice, Michael D. Hack, Alejandro Santillán, John J. M. Wiener, Karen Joy Shaw and Magda F. Morton and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron Letters.

In The Last Decade

Brett D. Allison

15 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett D. Allison United States 9 248 115 54 31 29 15 344
Fuk‐Wah Sum United States 11 271 1.1× 214 1.9× 51 0.9× 25 0.8× 16 0.6× 13 485
Daniele Andreotti Italy 13 291 1.2× 190 1.7× 47 0.9× 13 0.4× 17 0.6× 34 507
Jailall Ramnauth United States 14 315 1.3× 151 1.3× 31 0.6× 13 0.4× 9 0.3× 22 451
Hollis S. Kezar United States 10 241 1.0× 224 1.9× 45 0.8× 12 0.4× 8 0.3× 15 447
Michael C. Badia United States 7 148 0.6× 222 1.9× 16 0.3× 45 1.5× 21 0.7× 8 333
Christoph Pöverlein Germany 9 111 0.4× 121 1.1× 48 0.9× 8 0.3× 7 0.2× 15 291
Tuan P. Tran United States 11 183 0.7× 176 1.5× 61 1.1× 25 0.8× 39 1.3× 14 337
Kirk L. Sorgi United States 12 417 1.7× 181 1.6× 41 0.8× 16 0.5× 4 0.1× 27 477
Laurent Gomez United States 13 284 1.1× 239 2.1× 75 1.4× 27 0.9× 56 1.9× 26 459
Timothy C. Barden United States 9 230 0.9× 75 0.7× 23 0.4× 8 0.3× 9 0.3× 18 304

Countries citing papers authored by Brett D. Allison

Since Specialization
Citations

This map shows the geographic impact of Brett D. Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett D. Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett D. Allison more than expected).

Fields of papers citing papers by Brett D. Allison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett D. Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett D. Allison. The network helps show where Brett D. Allison may publish in the future.

Co-authorship network of co-authors of Brett D. Allison

This figure shows the co-authorship network connecting the top 25 collaborators of Brett D. Allison. A scholar is included among the top collaborators of Brett D. Allison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett D. Allison. Brett D. Allison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Allison, Brett D., et al.. (2022). Selective Metalation of Functionalized Quinazolines to Enable Discovery and Advancement of Covalent KRAS Inhibitors. Organic Process Research & Development. 26(10). 2926–2936. 4 indexed citations
2.
Préville, Cathy, Pascal Bonaventure, Tatiana Koudriakova, et al.. (2020). Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793. ACS Medicinal Chemistry Letters. 11(10). 2002–2009. 6 indexed citations
3.
Mani, Neelakandha S., et al.. (2018). The synthesis of 2-amino-4(3H)-quinazolinones and related heterocycles via a mild electrocyclization of aryl guanidines. Tetrahedron Letters. 59(17). 1623–1626. 4 indexed citations
4.
Allison, Brett D. & Neelakandha S. Mani. (2017). Gram-Scale Synthesis of a β-Secretase 1 (BACE 1) Inhibitor. ACS Omega. 2(2). 397–408. 8 indexed citations
5.
Morton, Magda F., Terrance D. Barrett, Jamie Freedman, et al.. (2011). JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability. Journal of Pharmacology and Experimental Therapeutics. 338(1). 328–336. 5 indexed citations
6.
McClure, Kelly J., Michael P. Maher, Nancy Wu, et al.. (2011). Discovery of a novel series of selective HCN1 blockers. Bioorganic & Medicinal Chemistry Letters. 21(18). 5197–5201. 25 indexed citations
7.
Santillán, Alejandro, Kelly J. McClure, Brett D. Allison, et al.. (2010). Indole- and benzothiophene-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(21). 6226–6230. 10 indexed citations
8.
Allison, Brett D., Lina Li, Magda F. Morton, et al.. (2009). Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: Discovery of CCKR1 selectivity in a previously CCKR2-selective lead series. Bioorganic & Medicinal Chemistry Letters. 19(22). 6373–6375. 10 indexed citations
9.
Rosen, Mark D., Michael D. Hack, Brett D. Allison, et al.. (2008). Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis. Bioorganic & Medicinal Chemistry. 16(7). 3917–3925. 7 indexed citations
10.
Woods, Craig R., Michael D. Hack, Brett D. Allison, et al.. (2007). Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands. Bioorganic & Medicinal Chemistry Letters. 17(24). 6905–6909. 8 indexed citations
11.
Wiener, John J. M., Laurent Gomez, Hariharan Venkatesan, et al.. (2007). Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains. Bioorganic & Medicinal Chemistry Letters. 17(10). 2718–2722. 50 indexed citations
12.
Evans, David A., Brett D. Allison, Michael G. Yang, & C. E. Masse. (2001). The Exceptional Chelating Ability of Dimethylaluminum Chloride and Methylaluminum Dichloride. The Merged Stereochemical Impact of α- and β-Stereocenters in Chelate-Controlled Carbonyl Addition Reactions with Enolsilane and Hydride Nucleophiles. Journal of the American Chemical Society. 123(44). 10840–10852. 116 indexed citations
13.
Evans, David A., Brett D. Allison, & Michael G. Yang. (1999). Chelate-controlled carbonyl addition reactions. The exceptional chelating abilityof dimethylaluminum chloride and methylaluminum dichloride. Tetrahedron Letters. 40(24). 4457–4460. 44 indexed citations
14.
Evans, David A., et al.. (1999). Chelation-controlled stannylacetylene additions to β-alkoxy aldehydes promoted by alkylaluminum halide Lewis acids. Tetrahedron Letters. 40(24). 4461–4462. 43 indexed citations
15.
Gribble, Gordon W., et al.. (1992). SYNTHESES OF 2,3-DIHALO-1-(PHENYLSULFONYL)INDOLES. Organic Preparations and Procedures International. 24(6). 649–654. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuk‐Wah Sum Breakdown of academic impact, for papers by Daniele Andreotti Breakdown of academic impact, for papers by Jailall Ramnauth Breakdown of academic impact, for papers by Hollis S. Kezar Breakdown of academic impact, for papers by Michael C. Badia Breakdown of academic impact, for papers by Christoph Pöverlein Breakdown of academic impact, for papers by Tuan P. Tran Breakdown of academic impact, for papers by Kirk L. Sorgi Breakdown of academic impact, for papers by Laurent Gomez Breakdown of academic impact, for papers by Timothy C. Barden
Rankless by CCL
2026